FDA Approved: BEPOTASTINE BESILATE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Mylan's original application for bepotastine besilate ophthalmic solution as a generic treatment for allergic conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• Bepotastine Besilate Ophthalmic Solution (bepotastine besilate)

Snippet

ORIG AP for BEPOTASTINE BESILATE (BEPOTASTINE BESILATE)